We are happy to announce that the Montis Capital fund has invested over 7 mln PLN in the  Biotts SA. Biotts – a Wroclaw-based startup – is developing innovative carriers of medical substances as well as drug compositions. Its flagship transdermal carrier can transport particles deep into the skin. The Biotech company has also recently […]

11.2 million PLN – this is the amount of funding we have received under the “Fast Track” programme of the National Centre for Research and Development (NCBR) to develop antidiabetic therapies (a project worth nearly 15 million PLN). The effectiveness of the Biotts carrier itself in innovative therapies has been confirmed by preclinical studies for […]

The Start-Up-Med is an event accompanying the 5th Health Challenges Congress. It aims to find, acknowledge and promote: a) The start-ups that stand behind the most creative product or process innovations, which are of significant importance to patients and the healthcare system as a whole, and are also cost-effective in implementation, including broadly understood medical technologies, both drug […]

Biotechnologia.pl: – The effectiveness of our carrier is being confirmed by preclinical studies as we speak. Biotts carriers can be used as a transport system for commonly used drugs. And such solutions are eagerly awaited by both patients and pharmaceutical companies, says dr Paweł Biernat, CEO of Wrocław-based Biotts. – Indeed, the effectiveness of any preparation depends not […]

The latest issue of Puls Biznesu Weekend features an in-depth article where we not only discuss the origins of our company but also reveal some of corporate plans for the future. To give you just a quick insight into the text: “Owing to a technology developed by Wrocław-based Biotts, i.e. the technology of transdermal penetration of drugs, patients will be able […]

Top Disruptors in Healthcare is a handbook of the start-up world. This is where you will find information on innovative solutions available on the Polish market. The project patrons include the Ministry of Health, National Centre for Research and Development (NCBiR), Polish Development Fund (PFR), and the Medical Research Agency (ABM). Astra Zeneca, Medicover and PZU Zdrowie […]